Boise, Idaho, June 2, 2023 – Jasper Health is excited to announce its commitment to CancerX as a founding member alongside world-renowned organizations and institutions within the healthcare, digital health, oncology, pharmaceutical industries.

Announced today at ASCO, CancerX – a public-private partnership co-hosted by Moffitt Cancer Center and the Digital Medicine Society (DiMe), alongside the Office for the National Coordinator for Health Information Technology (ONC) and Office of the Assistant Secretary for Health (OASH) announced its full lineup of founding members, including Jasper Health. See the full list here.

CancerX was announced by U.S. President Joe Biden and Dr. Jill Biden in February 2023 as part of The White House’s reignited national Cancer Moonshot initiative. This group will drive the success of CancerX, collaborating to set priorities and practices that will help harness the full power of innovation to achieve the goals of the Cancer Moonshot.

“Jasper Health’s mission to provide people affected by cancer and their caregivers with personalized digital and human-led support to improve quality of life and outcomes is a perfect fit with the purpose of CancerX,” says Jasper Health’s Co-Founder and CEO Adam Pellegrini. “We are honored to join such an esteemed group of founding members and look forward to the collective progress and momentum to push forward healthy equity in cancer care support.”

Organizations whose missions are aligned with the Cancer Moonshot goals have come together under CanceX to work together to surface innovative solutions and coordinate access to research, mentorship, resources, and other collaborative opportunities. This work will help startups, like Jasper Health, scale their business and work toward creating ‘challenge-focused’ solutions for cancer with health equity in mind.

Media Contact:
Elise Telford
[email protected]